Project Klinische Prüfung LTS11210 (SARIL-RA-EXTEND) - SAR153191 (Sarilumab)

Basic data

Title:
Klinische Prüfung LTS11210 (SARIL-RA-EXTEND) - SAR153191 (Sarilumab)
Duration:
01/07/2013 to 31/07/2019
Abstract / short description:
A multi-center, uncontrolled extension study evaluating efficacy and safety of sarilumab in patients with active Rheumatoid Arthritis (RA) - LTS11210 - SARIL-RA-EXTEND - mit der Substanz SAR153191 - Sarilumab.
Keywords:
Sarilumab
rheumatoid arthritis
Rheumatoide Arthritis

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Internal Medicine Department II
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

Frankfurt am Main, Hessen, Germany
Help

will be deleted permanently. This cannot be undone.